Stock PBM PSYENCE BIOMEDICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Psyence Biomedical Ltd.

Equities

PBM

CA74449F1009

End-of-day quote Nasdaq
Other stock markets
 18:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
0.329 USD -7.53% Intraday chart for Psyence Biomedical Ltd. -15.64% -96.44%
03-18 Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin CI
03-12 Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
CI
Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study
CI
Psyence Biomedical Ltd. Appoints Neil Maresky as CEO
CI
Psyence Biomedical Ltd. Appoints Warwick-Corden Lloyd as CFO
CI
Psyence Biomedical Ltd. Announces Board Appointments
CI
Psyence Therapeutics Corp.(NasdaqGM:PBM) added to NASDAQ Composite Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBM Stock
  4. News Psyence Biomedical Ltd.